TB-500 Cardiac Ischemia Research: STEMI Trial Findings
A 2025 RCT and preclinical study examined recombinant thymosin beta-4's effects on cardiac function after ischemia-reperfusion injury in STEMI patients.
A 2025 RCT and preclinical study examined recombinant thymosin beta-4's effects on cardiac function after ischemia-reperfusion injury in STEMI patients.